Roilan Garcia Noblet. MD

Goal-oriented General Practitioner with extensive knowledge of Internal Medicine, Geriatric Medicine and Clinical Research. Known for caring and individualized patient communication and top-notch treatment planning. Compassionate and organized individual with great attention to detail.

Spanish Medical interpreter BRIDGING THE GAP

Certified Surgical Assistant-AMERICAN BOARD SURGICAL ASSISTANT

Medical Assistant/ECG technician

American Heart Association: BLS, ACLS, PALS.

Internal Medicine, Family Medicine and Pediatric

https://promociondeeventos.sld.cu/ventilacion2010/posters/ Transfer of the critical patient, artificial route and ventilation, Dr. Roilan Garcia Noblet. http://www.revinfcientifica.sld.cu/index.php/ric/rt/printerFriendly/480/0 Influence of Risk Factors on Breastfeeding, Dr. Roilan Garcia Noblet.

http://www.revinfcientifica.sld.cu/index.php/ric/article/view/442, Educational intervention in mothers of Santa Catalina on knowledge of acute respiratory infection http://www.revinfcientifica.sld.cu/index.php/ric/article/view/1220, Clinical chromatosemiology of urine; Roilan Garcia Noblet. http://www.revinfcientifica.sld.cu/index.php/ric/article/view/441, Characterization of diabetes mellitus in the Health area of Paraguay, Roilan Garcia Noblet.

Internal Medicine Professor, University of Guantanamo-2005-2012.

Internal Medicine Professor, University of Guyana, 2012-2016.

Primary Care Physician with Dr. Raul A Martinez-Perez at Conviva Care. Hollywood, FL. January 2022 to Present

• Met with patients to discuss medical histories and current complaints.
• Ordered and executed various tests, analyses and diagnostic images to provide information on patient condition.
• Reviewed patient records, medications and immunization statuses.
• Conducted physical assessments of relevant body areas and performed standardized tests to check responses.

Emergency Care Physician with Dr. Jose O Alba  at Ponciana Hospital. Kissimmee FL. January 2023 to Present. 

• Performs triage on incoming patients to become part of the ER’s current load
• Oversees patient care, treatment, and recovery
• Participates in research efforts and clinical studies
• Maintains clinical records in line with regulations and standards
• Clears patients for discharge or further procedures with specialists
• Conducts follow-up to monitor patient’s condition

1-Jose O Alba: Emergency Medicine Board Certified: +1 646-301-3962; dr.josealba@gmail.com 

2-Raul A Martinez Perez:  Internal Medicine Board Certified +1 786-768-0218;  martinazo76@yahoo.es

• A phase1/2/3, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding Study to Evaluate the safety, tolerability, Inmunogenicity and Efficacy of SARS-COV-2 RNA Vaccine candidates against COVID-19 in healthy individuals.
• A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants (ENSEMBLE)
• Protocol I8B-MC-ITSW, A Study of LY900014 in Participants with type 2 Diabetes, using Continuous Glucose Monitoring
• A Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine Booster in Healthy Adults
• A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia
• A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants with Mild to Moderate COVID-19 Illness.
• A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy with Monoclonal Antibodies in Participants with Mild to Moderate COVID-19 Illness (BLAZE-4).
• A Phase 3 Randomized, Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Remdesivir (GS-5734TM)
• Treatment of COVID-19 in an Outpatient Setting. A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6‐DM]/Quinidine sulfate [Q]) for the
• Treatment of Negative Symptoms of Schizophrenia. A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of Dupilumab in Patients with Atopic Keratoconjunctivitis (AKC).
• An open-label, single-arm study to assess the safety and efficacy of LEBRIKIZUMAB in adolescent patients with moderate to Severe atopic dermatitis.
• A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of CBP-201 in Adult Subjects with Moderate to Severe Atopic Dermatitis
• A Randomized, Double-blind, Placebo-Controlled Trial Comparing the Efficacy and Safety of Three Tirzepatide Doses versus Placebo in Patients with Type 2 Diabetes, Inadequately Controlled with Diet and Exercise Alone (SURPASS-1).
• Effect of semaglutide versus placebo on the progression of renal impairment in subjects with type 2 diabetes and chronic kidney disease
• A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older
• Efficacy and Safety of Lumateperone for Treatment of Schizophrenia A Randomized Clinical Trial